#Micro cap stocks with potential driver#

The company focuses on immunotherapies for cancer. This year, FATE stock reached highs of over $120 and currently trades around $87. These are times where you hear traders say, вЂњwhy didnвЂ™t I hear about that company before?вЂќ For instance, a little more than 1 year ago, Fate Therapeutics ( NASDAQ: FATE) traded around $16 a share. One of the novelties of this world of cancer stocks is the multiple instances of вЂњovernight success.вЂќ While we know that nothing happens overnight, key developments made by some of the smaller companies in the industry can blossom into huge windfalls. YouвЂ™ve also got Johnson & Johnson ( NYSE: JNJ) & AbbvieвЂ™s ( NYSE: ABBV) Imbruvica, which EvaluatePharma expects 2021 sales to come in at $7.6 Billion. Bristol Myers SquibbвЂ™s ( NYSE: BMY) Revlimid and Opdivo are expected to do a combined $21.5 Billion this year. ItвЂ™s further supported by expectations of more than $16 billion in 2021 sales, overall. MerkвЂ™s ( NYSE: MRK) Keytruda вЂ“ a cancer drug вЂ“ is expected to be a $2.7 Billion drug in 2021 as far as new sales are concerned. Evaluate predicts that ModernaвЂ™s COVID-19 vaccine will be the market leader by 2026.вЂќДeloitteвЂ™s data clearly demonstrates the size and scope of cancer treatments.

According to Evaluate, sales of COVID-19 vaccines though are expected to reach US$10 billion to US$15 billion in 2021, with the Pfizer/BioNTech vaccine forecast to be the top seller. Oncology accounts for six out of the 10 biggest new sales generators and four of the top 10 bestselling products.

#Micro cap stocks with potential driver#

The firm states that вЂњBeyond vaccines, oncology is expected to continue to be a major driver of the sectorвЂ™s topline growth in 2021. In DeloitteвЂ™s 2021 Global Life Sciences Outlook*, the data is even more compelling in favor of oncology companies. In many cases, these can start out as penny stocks and quickly evolve into industry stand-outs. But weвЂ™re also talking about organizations developing truly novel treatments for humankind. Yes, weвЂ™re talking about companies in an industry working to tackle the second largest cause of death worldwide after cardiovascular disease. Should Penny Stocks Be On Your List In 2021?Д¬ancer stocks are some of the most popular among investors.